We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Orexigen’s Contrave Gains Panel Endorsement for Weight Loss
Orexigen’s Contrave Gains Panel Endorsement for Weight Loss
December 10, 2010
Orexigen Therapeutics has bucked the recent negative trend among prescription weight-loss drugs with an FDA advisory committee recommending approval for Contrave.